GO TO NEWSROOMeast
GUERBET: Résultats annuels 2019
March 24, 2020 12:48 ET | GUERBET
Résultats annuels 2019    Croissance du chiffre d'affaires à 816,9 M€ conforme aux objectifs Chiffre d’affaires de 816,9 M€ en progression de 3,5%Chiffre d’affaires taux de change constant de...
DELFINGEN Industry : Impact de la crise sanitaire COVID-19 sur l’activité du Groupe DELFINGEN
March 24, 2020 12:40 ET | DELFINGEN Industry
COMMUNIQUE DE PRESSEAnteuil, le 24 mars 2020 Face à la pandémie de COVID-19, DELFINGEN prend les dispositions les plus adaptées à cette situation exceptionnelle afin d’assurer au mieux la...
Brim hf.: Upplýsingar um breytta framkvæmd aðalfundar
March 24, 2020 12:37 ET | Brim hf.
Aðalfundur Brims hf. verður haldinn þriðjudaginn 31. mars kl. 17:00. Þar sem heilbrigðisráðherra hefur ákveðið, í samræmi við tillögu sóttvarnarlæknis, að takmarka samkomur vegna útbreiðslu...
Endanleg dagskrá og tillögur fyrir aðalfund Brims hf. 31. mars 2020
March 24, 2020 12:33 ET | Brim hf.
Aðalfundur Brims hf. verður haldinn þriðjudaginn 31. mars 2020 og hefst hann klukkan 17:00. Fundurinn fer fram á íslensku. Dagskrá Skýrsla stjórnar félagsins um starfsemina síðastliðið...
Schibsted_Logotype_L1_Dust-black_RGB-300x54.png
Schibsted ASA (SCHA/SCHB) – Annual accounts 2019 approved, cancelled proposal for 2019 dividend
March 24, 2020 12:14 ET | Schibsted
The Board of Directors and management of Schibsted ASA are taking measures to respond to the uncertain situation created by the ongoing COVID-19 pandemic. The Board has, in full agreement with...
BILD Supports Government Decision to Deem Construction Sites an “Essential Workplace” as a Necessary Balance Between Protecting Health and Safety of Workers and Delivering Necessary Housing Toronto, March 24, 2020 (GLOBE NEWSWIRE) -- Today’s announcement by the Provincial Government that deems construction sites as “essential workplaces” is vital to balance the health and safety of...
Resverlogix 臨床候選產品 Apabetalone 在近期刊物中被視為潛在的 COVID-19 治療藥物
March 24, 2020 12:05 ET | Resverlogix Corp
阿爾伯塔省卡爾加里, March 25, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. (「Resverlogix」或「公司」) (TSX:RVX),欣然宣佈 2020 年 3 月 23 日的 bioRxiv 刊物顯示 apabetalone 可抑制專業化蛋白質,或稱為溴結構域和末端外蛋白 (bromodomain and extraterminal...
近期出版物对Resverlogix临床候选药物Apabetalone作为新冠肺炎(COVID-19)潜在治疗药物进行专题报道
March 24, 2020 12:05 ET | Resverlogix Corp
阿尔伯塔省卡尔加里, March 25, 2020 (GLOBE NEWSWIRE) -- Resverlogix...
ReportLinker logo.jpg
Novel Coronavirus (COVID-19) - Preventive Vaccines, Therapeutics and Diagnostics in Development
March 24, 2020 11:51 ET | ReportLinker
New York, March 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Novel Coronavirus (COVID-19) - Preventive Vaccines, Therapeutics and Diagnostics in Development" -...
unnamed.png
Emerging Markets Report: Hoth Therapeutics is Working on a Potential Coronavirus Vaccine (COVID-19) An Emerging Markets News Commentary ORLANDO, Fla., March 24, 2020 (GLOBE NEWSWIRE) -- Bright and early Monday morning, Hoth Therapeutics, Inc. (NASDAQ: HOTH) released news that the Company had...